Stay updated on Semaglutide for Diabetic Eye Disease Clinical Trial
Sign up to get notified when there's something new on the Semaglutide for Diabetic Eye Disease Clinical Trial page.

Latest updates to the Semaglutide for Diabetic Eye Disease Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedThe webpage has removed a notice regarding heavy traffic affecting certain services and products, as well as a specific date. Additionally, a future date has been added.SummaryDifference6%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check42 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check56 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check64 days agoChange DetectedThe website has added a new version (v2.14.0) of the 'type of intervention' feature on January 8, 2025, following the removal of the previous version (v2.13.3) on November 19, 2024.SummaryDifference2%
- Check93 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
Stay in the know with updates to Semaglutide for Diabetic Eye Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide for Diabetic Eye Disease Clinical Trial page.